MHRA Contraindicates Domperidone in Phaeochromocytoma Dr Sheena Meredith

https://www.medscape.com/viewarticle/mhra-contraindicates-domperidone-phaeochromocytoma-2026a1000otk?src= Domperidone is now contraindicated in patients with confirmed or suspected phaeochromocytoma because of the risk of severe hypertension, the Medicines and Healthcare products Regulatory Agency (MHRA) has said in a new drug safety update. The update follows a European review of domperidone safety data that identified four reports of severe hypertension in these patients.

MRI-Based Staging Matches Digital Rectal Examination Accuracy in Prostate Cancer Survival Edited by Mamta Pawara

https://www.medscape.com/viewarticle/mri-based-staging-matches-digital-rectal-examination-2026a1000omm?src= Preoperative MRI-based T staging demonstrated oncologic risk discrimination comparable to traditional digital rectal examinations (DREs) for predicting survival outcomes in men with clinically localised or locally advanced prostate cancer (PCa) who underwent radical prostatectomy, a multicentre study found.

Stem Cell Transplant Associated With Better PFS in Natural Killer/T-Cell Lymphoma Edited by Katie Lennon July 24, 2026 Am J Hematol. 2026; doi:10.1002/ajh.70415

https://www.medscape.com/viewarticle/stem-cell-transplant-associated-better-pfs-natural-killer-t-2026a1000p7b?src= Upfront autologous stem cell transplantation (ASCT) consolidation is associated with improved progression-free survival (PFS) in patients with advanced-stage extranodal natural killer/T-cell lymphoma (NKTCL) who achieve a first complete remission after frontline therapy. Among 107 patients studied, those receiving ASCT had a 3-year PFS rate of 78.2% compared with 54.6% in the non-ASCT group.

Oncology News +++ ++ +...

Oncology News Stem Cell Transplant Associated With Better PFS in NKTCL Researchers aim to evaluate the effectiveness of ASCT as consolidation therapy for patients with advanced-stage natural killer/T-cell lymphoma who have attained their first complete remission. Medscape Medical News, July 24, 2026 https://www.medscape.com/viewarticle/stem-cell-transplant-associated-better-pfs-natural-killer-t-2026a1000p7b Drinking Water Contaminants Tied to Uterine Cancer Risk A large study links long-term exposure to disinfection byproducts in drinking water to uterine cancer, but experts stress the limitations of the data. Medscape Medical News, July 24, 2026 https://www.medscape.com/viewarticle/drinking-water-contaminants-tied-uterine-cancer-risk-2026a1000p62 Radiation Deserts Grow as Rural Radiation Sites Are Lost More than 50 million Americans live in counties without a radiation oncology practice site as rural and community-based centers disappear at higher rates. Medscape Medical News, July 24, 2026 https://www.medscape.com/viewarticle/radiation-deserts-grow-rural-radiation-sites-are-lost-2026a1000p5s MRI Staging Matches DRE Accuracy in Prostate Cancer Survival A multicentre study shows that MRI-based local T staging provides risk discrimination similar to digital rectal examinations for clinically localised or locally advanced prostate cancer. Medscape News UK, July 24, 2026 https://www.medscape.com/viewarticle/mri-based-staging-matches-digital-rectal-examination-2026a1000omm Glioma Outcomes Shaped by Subtype More Than Tx Sequence In high-risk low-grade glioma, starting with temozolomide or radiotherapy yields similar survival. Medscape Medical News, July 24, 2026 https://www.medscape.com/viewarticle/glioma-outcomes-shaped-subtype-more-than-treatment-sequence-2026a1000p3z Smoldering Myeloma: The Treatment Issue Is Getting Trickier An FDA approval, striking CAR T data, and a field that can't agree on what to do next. Experts weigh in on the most contentious question in myeloma. Medscape Medical News, July 23, 2026 https://www.medscape.com/index/list_13474_0

Younger Than 50 Years: New Research Reveals Trends Damian McNamara, MA July 23, 2026

https://www.medscape.com/viewarticle/colorectal-cancer-screening-adults-younger-than-50-years-new-2026a1000oxg?ecd=WNL_trdalrt_pos1_ous_260724_etid8534150&uac=148436CN&impID=8534150 The proportion of Americans younger than 50 years getting screened for colorectal cancer has increased in the past 5 years since guidelines lowered the minimum age to 45 years. However, not all gains have been equitable, with screening rates varying by race/ethnicity, income, and age in two recent studies that examined the success of the recommendations for expanding screening.

Advancing Care in HER2-Mutated NSCLC: Evidence, Diagnostics, and Future Directions Authors: Balazs Halmos, MD, MS

https://www.medscape.org/viewarticle/advancing-care-her2-mutated-nsclc-evidence-diagnostics-and-2026a1000d6g?page=1&src=mkmcmr_driv_stan_mscpedu_260724-OUS-HONC-advancing-care-her2-mutated-nsclc-evidence-diagnostics-and-2026a1000d6g-cta&uac=148436CN

Short-term immunosuppressive therapy briefly restores autism-like brain changes in adult mice

https://www.news-medical.net/news/20260723/Short-term-immunosuppressive-therapy-briefly-restores-autism-like-brain-changes-in-adult-mice.aspx A new mouse study led by UCLA Health suggests that inflammation during pregnancy can trigger autism-like changes in offspring, but also that those brain and behavior effects may be rapidly but temporarily reversible in adulthood with a short-term dose of the immunosuppressive drug rapamycin.